Evidence map›Paper›PMID 11854220›Full record

ArticleInfection and immunity2002

Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1.

Catharina W Wieland, Britta Siegmund, Giorgio Senaldi, Michael L Vasil, Charles A Dinarello, Giamila Fantuzzi

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 78 citations in OpenAlex.

  1. Anthranilate ReducesAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. A genome-wide screen inJournal of bacteriology · 2026
    Article
  4. Article
  5. Heliyon · 2024
    Article
  6. Modeling Host-Pathogen Interactions inInternational journal of molecular sciences · 2024
    Review
  7. Sphingosine induction of theJournal of bacteriology · 2024
    Article
  8. Article
  9. The In Vivo and In Vitro Assessment of Pyocins in TreatingAntibiotics (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Role of Host and Bacterial Lipids inFrontiers in immunology · 2022
    Review
  12. Review
  13. International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Despite AntagonismFrontiers in microbiology · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Impact ofBeilstein journal of organic chemistry · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Catharina W WielandDepartment of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
Britta Siegmund
Giorgio Senaldi
Michael L Vasil
Charles A Dinarello
Giamila Fantuzzi
Amgen (United States) · USUniversity of Colorado Health · US

Funding

Yeast-based HTS Assay Technologies for ProteasesR01AI015614 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DINARELLO, CHARLES ANTHONY · 1985 to 2025
$8.5M
NOVEL CLASS OF PHOSPHOLIPASES--MOLECULAR PATHOGENESISR01HL062608 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI VASIL, MICHAEL L. · 1998 to 2007
$3.2M
Pathogenesis of Fever in ManR56AI015614 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DINARELLO, CHARLES ANTHONY · 2016 to 2016
$311k
PATHOGENESIS OF FEVER IN HUMANSR37AI015614 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DINARELLO, CHARLES ANTHONY · 1988 to 1998
–
NHLBI NIH HHS HL62608NHLBI NIH HHS R01 HL062608NIAID NIH HHS AI-15614NIAID NIH HHS R01 AI015614NIAID NIH HHS R56 AI015614
6 · The paper itself

Abstract

Chronic pulmonary infection with Pseudomonas aeruginosa is common in cystic fibrosis (CF) patients. P. aeruginosa lipopolysaccharide (LPS), phosholipase C (PLC), and exotoxin A (ETA) were evaluated for their ability to induce pulmonary inflammation in mice following intranasal inoculation. Both LPS and PLC induced high levels of tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta-6, gamma interferon (IFN-gamma), MIP-1 alpha MIP-2 in the lungs but did not affect IL-18 levels. ETA did not induce TNF-alpha and was a weak inducer of IL-1 beta, IL-6, macrophage inflammatory protein 1 alpha (MIP-1 alpha), and MIP-2. Remarkably, ETA reduced constitutive lung IL-18 levels. LPS was the only factor inducing IFN-gamma. LPS, PLC, and ETA all induced cell infiltration in the lungs. The role of interferon regulatory factor-1 (IRF-1) in pulmonary inflammation induced by LPS, PLC, and ETA was evaluated. When inoculated with LPS, IRF-1 gene knockout (IRF-1 KO) mice produced lower levels of TNF-alpha, IL-1 beta, and IFN-gamma than did wild-type (WT) mice. Similarly, a milder effect of ETA on IL-1 beta and IL-18 was observed for IRF-1 KO than for WT mice. In contrast, the cytokine response to PLC did not differ between WT and IRF-1 KO mice. Accordingly, LPS and ETA, but not PLC, induced expression of IRF-1 mRNA. IRF-1 deficiency had no effect on MIP-1 alpha and MIP-2 levels and on cell infiltration induced by LPS, PLC, or ETA. Flow cytometric evaluation of lung mononuclear cells revealed strongly reduced percentages of CD8(+) and NK cells in IRF-1 KO mice compared to percentages observed for WT mice. These data indicate that different virulence factors from P. aeruginosa induce pulmonary inflammation in vivo and that IRF-1 is involved in some of the cytokine responses to LPS and ETA.

Indexed as

Virulence FactorsADP Ribose TransferasesAnimalsBacterial ToxinsCytokinesDNA-Binding ProteinsExotoxinsFemaleInterferon Regulatory Factor-1Leukocyte CountLeukocytes, MononuclearLipopolysaccharidesLungMacrophage Inflammatory ProteinsMaleMiceADP Ribose TransferasesBacterial ToxinsCytokinesDNA-Binding ProteinsExotoxinsInterferon Regulatory Factor-1Irf1 protein, mouseLipopolysaccharidesMacrophage Inflammatory ProteinsPhosphoproteinsPseudomonas aeruginosa Exotoxin ATranscription FactorsType C PhospholipasesVirulence Factors

Identifiers

PMID11854220
PMCPMC127789
OpenAlexW2131267669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.